Tell us what's important to you. We'll build you a better ClevelandClinic.org.

close

Take the ClevelandClinic.org Improvement Survey Now!

Find the right doctor.Get information about our new institute structure.my health. MyChart.Find the right doctor.

Peter Rose, M.D.

Print this Content
Email this Content
Appointed: 2004
Gender: Male
Languages: English
Obstetrics and Gynecology

Section Head, Gynecologic Oncology

Phone:(216) 444-1712
Location:Cleveland Clinic Main Campus
Mail Code A81
9500 Euclid Avenue
Cleveland, OH 44195
 
 
Biographical Sketch

Peter G. Rose, MD, is Section Head and Fellowship Director of Gynecologic Oncology in the Department of Obstetrics and Gynecology at Cleveland Clinic. 

Dr. Rose attended the St. Louis School of Medicine in St. Louis, Mo., after completing his BA in biochemistry and biophysics from the University of Connecticut in Storrs, Conn.

Back to Top
Professional Highlights
  • Principal Investigator: Gynecologic Oncology Group, 1990-1992, 1995-Current
  • Study Chairman: Gynecologic Oncology Group, various trials
  • Study Chairman: SmithKline Beecham Pharmaceuticals. A Phase I study of oral topotecan and liposomal doxorubicin (Doxil) as second-line therapy in ovarian, peritoneal and tubal carcinoma. A Phase I/II study of carboplatin and topotecan as second-line therapy in platinum-sensitive ovarian or peritoneal carcinoma.
  • Study Chairman: Bristol-Myers Squibb Pharmaceuticals. A Phase II study of weekly paclitaxel and carboplatin as second-line therapy in platinum-sensitive ovarian or peritoneal carcinoma.
  • Study Chairman: Eli Lilly & Company. A phase II randomized study of gemcitabine and carboplatin utilizing two different dose schedules in patients with recurrent ovarian or peritoneal carcinoma.
Back to Top
Education & Fellowships
Medical School:Boston University School of Medicine, Boston, MA
Medical School:Saint Louis University School of Medicine, St. Louis, MO
 
Residency:The Ohio State University Hospitals, Obstetrics and Gynecology, Columbus, OH
Residency:Vanderbilt University, Surgery, Nashville, TN
Fellowship:Roswell Park Cancer Institute, Gynecologic Oncology, Buffalo, NY
Other Education:(Undergraduate) University of Connecticut, Storrs, CT
Back to Top
Additional Training
  • Laser Certification, Grant Hospital, Columbus, Ohio, 1984 
  • Laser Certification, Roswell Park Memorial Institute, Buffalo, N.Y., 1988 
Back to Top
Certifications

Gynecologic Oncology

Obstetrics & Gynecology

Back to Top
Specialty Interests
Gynecologic oncology.
Back to Top
Awards & Honors
  • Faculty Teaching Award, Department of Obstetrics and Gynecology, University of Massachusetts, 1991
  • Faculty Teaching Award, Department of Obstetrics and Gynecology, Mt. Sinai Hospital, Cleveland, Ohio, 1994
  • Association of Professors of Obstetrics and Gynecology (APGO), Medical Student Teaching Award, Department of Obstetrics and Gynecology, University Hospitals of Cleveland, 1998
  • Best Doctors, Cleveland magazine, 1998, 2002, 2004, 2006-2008
Back to Top
Professional Memberships
  • Gynecologic Oncology Group Principal Investigator (PI): 2/1990-11/1992, 2/1995-7/2002, 1/2004-Current; Affiliate PI: 11/1992-2/1995, 7/2002-1/2004; Member, Developmental Therapeutics Committee: 1/1996-Current (Section Head, Cervical Cancer 1/2003); Member, Phase I Committee: 1/1997-Current; Member, Ovarian Committee: 1/1998-Current
  • Fellow, American College of Surgeons, 1992-1998
  • New England Cancer Society, 1991-1992
  • New England Association of Gynecologic Oncologists; Candidate Member 1989, Member 1992-Current
  • Society of Gynecologic Oncologists; Candidate Member 1989, Member 1992; Member Education Committee, 1994-1997; Editor of SGO Issues, 1995-1998; Member of the Communications Committee, 1996-1997; Member of the Coding Committee, 1999-Current; Member of the Program Committee, 2001
Back to Top
Specializes in Diseases and Conditions
Back to Top
Specializes in Services
Back to Top
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 9/4/2008, Dr. Rose has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting.  Dr. Rose receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
  • Eli Lilly and Company
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)